Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
NAD+ and Sirt5 restore mitochondrial bioenergetics failure and improve locomotor defects caused by sucla2 mutations
Joy Richard, Giulia Lizzo, Noélie Rochat, Adrien Jouary, Pedro T.M. Silva, Alice Parisi, Stefan Christen, Sofia Moco, Michael B. Orger, Philipp Gut
Joy Richard, Giulia Lizzo, Noélie Rochat, Adrien Jouary, Pedro T.M. Silva, Alice Parisi, Stefan Christen, Sofia Moco, Michael B. Orger, Philipp Gut
View: Text | PDF
Research Article Cell biology Metabolism

NAD+ and Sirt5 restore mitochondrial bioenergetics failure and improve locomotor defects caused by sucla2 mutations

  • Text
  • PDF
Abstract

Mitochondria-derived acyl-coenzyme A (acyl-CoA) species chemically modify proteins, causing damage when acylation reactions are not adequately detoxified by enzymatic removal or protein turnover. Defects in genes encoding the mitochondrial respiratory complex and TCA cycle enzymes have been shown to increase acyl-CoA levels due to reduced enzymatic flux and result in proteome-wide hyperacylation. How pathologically elevated acyl-CoA levels contribute to bioenergetics failure in mitochondrial diseases is not well understood. Here, we demonstrate that bulk succinylation from succinyl-CoA excess consumes the enzymatic cofactor NAD+ and propagates mitochondrial respiratory defects in a zebrafish model of succinyl-CoA ligase deficiency, a childhood-onset encephalomyopathy. To explore this mechanism as a therapeutic target, we developed a workflow to monitor behavioral defects in sucla2–/– zebrafish and show that hypersuccinylation is associated with reduced locomotor behavior and impaired ability to execute food hunting patterns. Postembryonic NAD+ precursor supplementation restores NAD+ levels and improves locomotion and survival of sucla2–/– zebrafish. Mechanistically, nicotinamide and nicotinamide riboside require the NAD+-dependent desuccinylase Sirt5 to enhance oxidative metabolism and nitrogen elimination through the urea cycle. Collectively, NAD+ supplementation activates Sirt5 to protect against damage to mitochondria and locomotor circuits caused by protein succinylation.

Authors

Joy Richard, Giulia Lizzo, Noélie Rochat, Adrien Jouary, Pedro T.M. Silva, Alice Parisi, Stefan Christen, Sofia Moco, Michael B. Orger, Philipp Gut

×

Figure 6

Sirt5 and NAD+ improve survival, spontaneous swimming, and LFR.

Options: View larger image (or click on image) Download as PowerPoint
Sirt5 and NAD+ improve survival, spontaneous swimming, and LFR.
(A) Surv...
(A) Survival and (B) LFR of sucla2–/– and control zebrafish larvae with or without sirt5 overexpression (survival: WT, n = 24; sucla2–/–, n = 24; Tg(ubi:sirt5), n = 18; sucla2–/– Tg(ubi:sirt5); LFR: WT, n = 32; sucla2–/–, n = 14; sucla2–/– Tg(ubi:sirt5), n = 23, 7 dpf, fed ad libitum 5–7 dpf). (C and D) Quantification of (C) movement amplitude per individual and (D) number of events in response to LFR. Data pooled from 2 independent experiments. P values calculated by nonparametric tests (Kruskal-Wallis, 2 comparisons). (E) Survival curve and (F) histogram of 14 dpf of WT and sucla2–/– zebrafish larvae with and without sirt5–/– genetic background, treated with NAM/NR from 5 to 10 dpf (WT, n = 60; sucla2–/–, n = 51; sucla2–/– + 250 μM NAM/250 μM NR, n = 30; sucla2–/– sirt5–/– + 250 μM NAM/250 μM NR, n = 47, ad libitum fed). (G) Behavioral protocol: locomotor activity tracked for 10 minutes in dark condition. Spontaneous activity (SA) was quantified followed by 8 consecutive light flashes (1 second, followed by 29-second interstimulus dark intervals). Average responses represented as V1, first 2 seconds, and V2, the following 28 seconds. (H) SA and (J) average pattern of WT and sucla2–/– zebrafish larvae with and without sirt5 overexpression treated with 250 μM of NAM/NR for 40 hours. (I–L) Quantification of mean activity per individual (WT, n = 18; sucla2–/–, n = 20; sucla2–/– + NAM/NR, n = 8; sucla2–/– sirt5–/– + NAM/NR, n = 18, 7 dpf, fed). P values calculated by ordinary 1-way ANOVA with Tukey’s multiple-comparison test. Statistical analysis of survival curves (A and E) performed by log-rank test with Bonferroni’s correction. P values in F calculated by Fisher’s exact test. Box plots show median, first to third quartile, minima, maxima.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts